The sponsored activities planned during the 17th Lymphoma Congress were received with enormous interest and almost all have already been booked. We are proud to share with the most relevant companies in the field of lymphomas these opportunities for networking, growth and professional training, which are possible both in person in Lugano as well as remotely.
The Industry program will be open to all participants registered to the Conference, but attendance to each symposium may be restricted by the organising Company's own policies.
Independent satellite symposia will take place on Tuesday, June 13 and in the late afternoon of Wednesday 14, Thursday 15 and Friday 16: out of 23 slots available, 19 have been booked and will provide companies with the possibility to present important innovations and cutting-edge researches to our participants!
The symposia will be performed in-person and streamed live via the 17-ICML Virtual Platform.
The recordings will be available on-demand after the Conference (unless otherwise requested).
We are now pleased to share the titles of the symposia, here below!
Palazzo dei Congressi, 11:30 - 13:00
Room A, satellite symposium organized by Kite, A Gilead Company
Manufactoring excellence in CAR T for patient outcomes
Room B1, satellite symposium organized by Regeneron
Optimizing Treatment Paradigms for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) With the Emerging Class of Bispecific Antibodies
Room B2, satellite symposium organized by Eli Lilly and Company
Palazzo dei Congressi, 14:00 - 15:30
Room A, satellite symposium organized by Kite, A Gilead Company
Navigating new treatment options in R/R DLBCL
Room B1, satellite symposium organized by Novartis
Using Real-World Experience to Optimize CAR-T Cell Therapy in Lymphoma
Room B2, satellite symposium organized by Incyte
What to do when CAR Ts are not the most appropriate option in 2L DLBCL
Current treatment options for transplant-ineligible patients
USI, West Campus, 14:00 - 15:30
Auditorium, satellite symposium organized by MSD
Aggressive B-cell lymphomas, ROR1 modalities and ADCs: Why it Matters
Palazzo dei Congressi, 16:30 - 18:00
Room A, satellite symposium organized by Bristol Myers Squibb
Advances in the Management of B Cell Malignancies:
Updates and Future Directions
Room B1, satellite symposium organized by Genmab
Beyond the Horizon: Perspectives on the Treatment of Later-Line Large B-Cell Lymphoma (LBCL)
Room B2, satellite symposium organized by Roche
T-cell engaging bispecific antibodies in the management of relapsed/refractory follicular lymphoma
USI, West Campus, 16:30 - 18:00
Auditorium, satellite symposium organized by PeerView, supported by AstraZeneca
Taking the Leap in MCL: New Opportunities With BTK Inhibitors and Other Innovative Strategies
PeerView.com/Lugano23
Palazzo dei Congressi, 19:00 - 20:30
Room A, satellite symposium organized by Roche
What does the future hold for DLBCL treatment and prognosis?
Room B1, satellite symposium organized by Sobi
Closing the gap: Unmet Needs and Emerging Treatments in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Room B2, satellite symposium organized by AbbVie
Optimizing Treatment Strategies for Patients with Chronic Lymphocytic Leukemia (CLL): An Expert Discussion
Palazzo dei Congressi, 19:00 - 20:30
room A, satellite symposium organized by AbbVie
Navigating the Rapidly Changing Treatment Landscape in DLBCL
room B, satellite symposium organized by Takeda
The future of therapy for CD30+ lymphomas: addressing challenges and driving progress
USI, West Campus, 19:00 - 20:30
Auditorium, satellite symposium organized by BeiGene
Targeting BTK across B-Cell Malignancies – Selecting the right treatment for patients with lymphoma or CLL
Palazzo dei Congressi, 19:00 - 20:30
Room A, satellite symposium organized by Kite, A Gilead Company
How do we improve outcomes for underserved populations with B-cell lymphoma?
Room B, satellite symposium organized by Janssen
Optimizing treatment for patients with CLL and MCL now and in the future
https://www.janssencongress.com/emails/icml-2023-01/
Palazzo dei Congressi, room A, 18:00 -19:00
The Big Debate at 17-ICML
A satellite symposium organized by the Foundation for the Institute of Oncology Research (IOR) and supported by Gilead Sciences Europe Ltd, who provided funding.
MOVING TARGETS IN LYMPHOMA TREATMENT
Chair: Emanuele Zucca, Bellinzona, CH
DEBATE 1.
Best therapy in aggressive mantle cell lymphoma: Time for frontline chemotherapy-free regimens?
YES Michael L. Wang, Houston, TX, US
NO Martin Dreyling, Munich, DE
DEBATE 2.
Towards a cure for relapsing/refractory diffuse large B cell lymphoma: Bispecific antibodies better than CAR-T cells?
YES Laurie Sehn, Vancouver, CA
NO Gloria Iacoboni, Barcelona, ES
DEBATE 3.
Frontline treatment of advanced Hodgkin lymphoma: Should A+AVD replace PET-driven strategies?
YES Stephen M. Ansell, Rochester, MN, US
NO Peter Borchmann, Cologne, DE
The exhibition takes place in the “Marquee Parco Ciani”, a temporary structure facing the lake and directly connected to Palazzo dei Congressi. Twenty-one Companies already booked their spaces to dialogue with our attendees, up to 3’500 physicians, gathered in Lugano: junior and senior-level haematologists, medical oncologists, pathologists, radiation oncologists and leading researchers involved in the study and treatment of lymphoid neoplasms.
Marquee Parco Ciani will host the overflow area for the scientific sessions held in room B, the poster session and the commercial exhibition. Coffee breaks and lunch times will be organized in the Marquee as well.
The following industry partners will be present in the 17-ICML exhibition area:
AbbVie
Acrotech Biopharma, Inc.
AstraZeneca
BeiGene
Bristol Myers Squibb
CRISPR Therapeutics
Eli Lilly and Company
EUSA Pharma (UK), Ltd.
Genexpath
Genmab
Gilead and Kite Oncology
Incyte
Janssen
Kyowa Kirin
Miltenyi Biomedicine
Novartis
Pierre Fabre
Regeneron
Sobi
Takeda
Viracta
(by invitation only)
Rooms are available in Palazzo dei Congressi and in Il Ciani (a recently full-renovated building just opposite to Palazzo dei Congressi) for private meetings on a daily basis.
No black-out times are scheduled (ancillary meetings can take place in parallel with the Scientific Program).
Rental fees and availabilities can be requested by contacting Orietta Lugli (orietta.lugli@icml.ch).
Rental fees include standard set up (chairs and tables in a boarding, U-shape or conference set up) and basic technical equipment (laptop, screen and beamer, audio system if necessary).
In case a location outside the Conference center is more suitable, Amiconi Consulting SA, our partner for accommodation and local services, offers some meeting rooms located in hotels and in different locations of Lugano. Please contact the agency via e-mail at: info@amiconiconsulting.ch.
